James J. Burns & Company LLC Boosts Position in iShares Biotechnology ETF (NASDAQ:IBB)

James J. Burns & Company LLC increased its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 15.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,361 shares of the financial services provider’s stock after acquiring an additional 310 shares during the quarter. James J. Burns & Company LLC’s holdings in iShares Biotechnology ETF were worth $311,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also recently modified their holdings of IBB. BNP Paribas Financial Markets raised its position in iShares Biotechnology ETF by 29.3% in the third quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock valued at $346,561,000 after purchasing an additional 538,899 shares during the period. Healthcare of Ontario Pension Plan Trust Fund raised its holdings in iShares Biotechnology ETF by 32.9% in the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock valued at $96,533,000 after buying an additional 164,000 shares during the period. Aprio Wealth Management LLC purchased a new stake in iShares Biotechnology ETF in the 4th quarter valued at about $18,476,000. DRW Securities LLC acquired a new position in iShares Biotechnology ETF in the third quarter valued at about $5,990,000. Finally, Erste Asset Management GmbH purchased a new position in iShares Biotechnology ETF during the third quarter worth about $5,678,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

iShares Biotechnology ETF stock opened at $137.85 on Tuesday. The company’s 50 day simple moving average is $136.33 and its 200-day simple moving average is $141.50. iShares Biotechnology ETF has a 1 year low of $123.60 and a 1 year high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The company also recently declared a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were paid a dividend of $0.0624 per share. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.